Iovance Biotherapeutics Inc

IOVA(Iovance Biotherapeutics Inc)

$10.79+6.3%

IOVA(Iovance Biotherapeutics Inc) Price Prediction Summary

AI-Generated
As of September 24, 2026, IOVA is currently trading in an established uptrend with price firmly above all key moving averages and positive MACD momentum. The technical setup is distinctly bullish, supported by aligned SMA20/50/200 stacking and strong buy signals across the indicator suite. The primary uncertainty is RSI\'s overbought reading at 70.52, which limits near-term upside potential and raises consolidation risk before new highs. Watch for RSI mean reversion and any pause at the 20-day moving average \(9.14\) as a potential springboard for the next leg higher, or a dip toward the 50-day support \(7.28\) if profit-taking accelerates.
Technical Indicators
Strong Uptrend, Overbought

Moving averages in full bullish alignment, MACD positive; RSI reading suggests momentum may need consolidation.

Key Trading Levels

How Gate Predicts IOVA(Iovance Biotherapeutics Inc) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of September 24, 2026, **IOVA technical analysis** shows a commanding uptrend with price trading well above all key moving averages. The SMA20 sits at 9.14, SMA50 at 7.28, and SMA200 at 4.40—all in bullish stacking order, confirming sustained upside momentum. MACD at 0.88 reinforces the buy signal with positive histogram divergence, indicating continued bullish pressure. The RSI14 reading of 70.52, however, flags overbought territory, suggesting the near-term IOVA price forecast may face near-term pullback risk despite the strong intermediate trend. All three moving averages generate buy signals, cross-validating the uptrend\'s strength. The divergence between MACD\'s bullish confirmation and RSI\'s overbought warning suggests caution; further upside may require a brief consolidation or minor pullback to reset momentum indicators. Watch for support at the SMA50 \(7.28\) and resistance near recent highs; RSI mean reversion below 70 would signal renewed buying opportunity on dips.
IndicatorValueSignal
Exponential Moving Average (10)9.9653
Buy
Exponential Moving Average (100)6.3288
Buy
Exponential Moving Average (20)9.2732
Buy
Exponential Moving Average (200)5.1349
Buy
Exponential Moving Average (30)8.6743
Buy
Exponential Moving Average (50)7.7304
Buy
Hull Moving Average (9)10.6896
Buy
Ichimoku Base Line (9, 26, 52, 26)9.085
neutral
Moving Averages Summary—
neutral
Simple Moving Average (10)9.918
Buy
Simple Moving Average (100)5.6421
Buy
Simple Moving Average (20)9.164
Buy
Simple Moving Average (200)4.4007
Buy
Simple Moving Average (30)8.692
Buy
Simple Moving Average (50)7.2865
Buy
Volume Weighted Moving Average (20)9.3699
Buy
Average Directional Index (14)54.9944
neutral
Awesome Oscillator1.9748
neutral
Bull Bear Power1.4911
neutral
Commodity Channel Index (20)119.7195
Sell
MACD Level (12, 26)0.9129
Buy
Momentum (10)2.66
Buy
Oscillators Summary—
neutral
Relative Strength Index (14)73.1457
neutral
Stochastic %K (14, 3, 3)85.1474
neutral
Stochastic RSI Fast (3, 3, 14, 14)78.1399
neutral
Ultimate Oscillator (7, 14, 28)54.9136
neutral
Williams Percent Range (14)-6.1224
neutral
Technical Summary—
neutral

Market Sentiment

AI-GeneratedNo data yet
Analyst Rating
--
Options Put/Call Ratio
25.4400%
Implied Volatility (IV)
5.2245

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the IOVA(Iovance Biotherapeutics Inc) price prediction?

x

IOVA(Iovance Biotherapeutics Inc) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the IOVA(Iovance Biotherapeutics Inc) price prediction?

x

How are technical indicators used in the IOVA(Iovance Biotherapeutics Inc) price prediction?

x

What role does market sentiment play in the IOVA(Iovance Biotherapeutics Inc) price prediction?

x

What common factors can influence the IOVA(Iovance Biotherapeutics Inc) price prediction?

x

How can price predictions be used to assess the current market state of IOVA(Iovance Biotherapeutics Inc)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.